Tiollais, P, et al.
The hepatitis B virus. Nature
1985; 317: 489–495.
Locarnini, S, et al.
Molecular genetics of HBV infection. Antiviral Therapy
2010; 15 (Suppl. 3): 3–14.
Desmond, CP, et al.
A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics. Antiviral Therapy
2008; 13: 161–175.
Chen, P, et al.
Computational evolutionary analysis of the overlapped surface (S) and polymerase (P) region in hepatitis B virus indicates the spacer domain in P is crucial for survival. PLoS ONE
2013; 8: e60098.
Coleman, PF. 2006. Detecting hepatitis B surface antigen mutants. Emerging Infectious Diseases
Chiou, HL, et al.
Altered antigenicity of ‘a’ determinant variants of hepatitis B virus. Journal of General Virology
1997; 78: 2639–2645.
Chen, HB, et al.
A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene. World Journal of Gastroenterology
2003; 9: 304–308.
Ogura, Y, et al.
1999. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. Journal of Infectious Diseases
1999; 180: 1444–1451.
Yamamoto, K, et al.
Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. Journal of Virology
1994; 68: 2671–2676.
Purdy, MA. Hepatitis B virus S gene escape mutants. Asian Journal of Transfusion Science
2007; 1: 62–70.
Sticchi, L, et al.
Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. Human Vaccines & Immunotherapeutics
2013; 9: 568–571.
Fang, ZL, et al.
Prevalence of hepatitis B virus infection in a highly endemic area of southern China after catch-up immunization. Journal of Medical Virology
2012; 84: 878–884.
Gunther, S, et al. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. Journal of Virology
1995; 69: 5437–44.
Hall, TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series
1999; 41: 95–98.
Tamura, K, et al.
MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Molecular Biology and Evolution
2013; 30: 2725–2729.
Ireland, JH, et al.
Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology
2000; 31: 1176–82.
Yong-Lin, Y, et al.
Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virology Journal
2012; 9: 82.
Avellón, A, et al.
Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. Journal of Medical Virology
2006; 78: 24–36.
Mascagni, P, et al.
Characterisation of an HBsAg mutant of hepatitis B virus (HBV) isolated from a dialysed patient involved in an occupational accident [in Italian]. La Medicina del Lavoro
2005; 96: 231–237.
Lazarevic, I, et al.
Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia. Journal of Medical Virology
2010; 82: 1160–1167.
Song, BC, et al.
Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. Journal of Medical Virology
2005; 76: 194–202.
Sayiner, AA, et al.
Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus. Journal of Medical Virology
2008; 80, 405–410.
Kitab, B, et al.
Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. Journal of Infection
2011; 63: 66–75.
Roque-Afonso, AM, et al.
Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers. Antiviral Therapy
2007; 12: 1255–1263.
Shi, Y, et al.
Mutations in the major hydrophilic region (MHR) of hepatitis B virus genotype C in North China. Journal of Medical Virology
2012; 84: 1901–1906.
Liu, Y, et al.
Molecular epidemiological study of hepatitis B virus in blood donors from five Chinese blood centers. Archives of Virology
2012; 157: 1699–1707.
Pourkarim, MR, et al.
Evolutionary analysis of HBV ‘S’ antigen genetic diversity in Iranian blood donors: a nationwide study. Journal of Medical Virology
2014; 86: 144–155.
Panigrahi, R, et al.
Subgenotype D5, BCP and MHR mutations in hepatic complications among hepatitis B virus infected patients from Orissa, India. Infection, Genetics and Evolution
2012; 12: 1622–1629.
Niu, J, et al.
Variability of the S gene of hepatitis B virus in southeastern China. Archives of Virology
2010; 155: 1951–1957.
Yuan, TT, et al.
The mechanism of natural occurrence of two closely linked HBV precore predominant mutations. Virology
1995; 211: 144–156.
Sung, JJ, et al.
Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. Journal of Virology
2008; 82: 3604–3611.
Mirandola, S, et al.
Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy. Antiviral Research
2012; 96: 422–429.
Echevarria, JM, et al.
2006. Hepatitis B virus genetic diversity. Journal of Medical Virology
2006; 78 (Suppl. 1): S36–42.
Villet, S, et al.
In vitro characterization of viral fitness of therapy-resistant hepatitis B variants. Gastroenterology
2009; 136: 168–176.
Yu, DM, et al.
N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape. Journal of Hepatology
2014; 60: 515–522.
Wang, Z, et al.
Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China. Journal of Viral Hepatitis
2007; 14: 426–434.
Wang, Z, et al.
Hepatitis B virus genotypes and subgenotypes in China. Hepatology Research
2007; 37 (Suppl. 1): S36–41.
Yuan, J, et al.
Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications. Journal of Clinical Virology
2007; 39: 87–93.